Valeant Must Sell Three Rx Dermatology Drugs To Acquire Dermik and Ortho Dermatologics

The Federal Trade Commission requires Valeant to sell BenzaClin and 5FU to Mylan and Refissa to Spear Pharmaceuticals; Valeant also must produce a backup supply of 5FU until Mylan can manufacture the drug commercially.